Core Viewpoint - The company is a national high-value medical device distributor, primarily engaged in direct sales and distribution of medical devices, providing centralized operation services for medical consumables to hospitals [2] Summary by Category Company Overview - The company started its subscription on September 16, with an issue price of 7.05 yuan per share, a pre-issue market value of 25.25 billion yuan, and an issue price-to-earnings (P/E) ratio of 13.29 times, compared to the industry average P/E ratio of 25.73 times [2] Financial Performance - Revenue projections from 2022 to 2024 are 11.88 billion, 15.44 billion, and 17.92 billion yuan, respectively, with a year-on-year growth of 16.06% in 2024 [2] - Net profit for the same period is projected to be 189.2 million, 226.9 million, and 273.8 million yuan, with a year-on-year growth of 20.68% in 2024 [2] - For the third quarter of 2025, the company expects revenue growth of 10% to 15% year-on-year, and net profit growth of 30% to 40%, with non-recurring net profit growth of 26% to 40% [2] Valuation Comparison - In comparison with peer companies, the company's dynamic and static P/E ratios indicate a relatively low valuation, with a dynamic P/E of 10.65 and a static P/E of 13.29 [3] - The company has a total market value of 29.71 billion yuan and a circulating market value of 4.46 billion yuan, with an issue price considered inexpensive [3] Market Sentiment - The company is state-owned, with a 51% shareholding by state-owned enterprises, and the expected price increase on the first day of trading is between 248.1% and 413.5% [3]

Group 1 - The article discusses the subscription details for the company Changjiang Nengke, including a subscription limit of 1.425 million shares and an issuance price of 5.33 yuan [1] - The industry price-earnings ratio is noted as 15.48, while the overall market price-earnings ratio is 36.78, indicating a potential valuation comparison [1]

Group 1: New Stock Offerings - Two new stocks are available for subscription: Rui Li Ke Mi (001285.SZ) on the Shenzhen Main Board and Yun Han Xin Cheng (301563.SZ) on the ChiNext Board, along with the listing of Shi Chang Co., Ltd. (920022.BJ) on the Beijing Stock Exchange [1] Group 2: Rui Li Ke Mi - Rui Li Ke Mi is a national high-tech enterprise specializing in the R&D, production, and sales of core components for active safety systems in motor vehicles [2] - The company holds a leading position in the commercial vehicle pneumatic electronic control braking system sector, with its brand "Kormee" recognized as a top industry brand [2] - From 2014 to 2023, Rui Li Ke Mi ranked first in the production and sales of braking anti-lock devices (ABS) for ten consecutive years, with a market share of 1st place from 2021 to 2023 [2] - The company has experienced significant revenue fluctuations, with projected revenues of 1.326 billion yuan, 1.76 billion yuan, and 1.977 billion yuan from 2022 to 2024, and net profits of 97 million yuan, 236 million yuan, and 269 million yuan respectively [3] Group 3: Yun Han Xin Cheng - Yun Han Xin Cheng is an innovative high-tech enterprise focusing on the distribution of electronic components and the integration of industrial internet, recognized as a leading B2B company in China's electronic components sector [4] - The company operates a B2B online marketplace and provides a one-stop supply chain service for the electronic manufacturing industry, including product design and PCBA manufacturing services [4] - Projected revenues for Yun Han Xin Cheng are 4.333 billion yuan, 2.637 billion yuan, and 2.577 billion yuan from 2022 to 2024, with net profits of 136 million yuan, 79 million yuan, and 88 million yuan respectively [4] Group 4: Shi Chang Co., Ltd. - Shi Chang Co., Ltd. specializes in the R&D, production, and sales of automotive fuel systems, particularly high-pressure plastic fuel tanks [6] - The company has established stable partnerships with major automotive manufacturers, including Geely, Chery, and BYD, and has seen significant revenue growth with total revenues of 282 million yuan, 406 million yuan, and 515 million yuan from 2022 to 2024, reflecting a compound annual growth rate of 35.23% [6] - Net profits for the same period are projected at 18.12 million yuan, 51.93 million yuan, and 69.24 million yuan, with a compound annual growth rate of 95.50% [6] Group 5: Industry Challenges - The automotive fuel tank industry faces challenges due to the rise of electric vehicles, which do not require fuel tanks, potentially reducing market demand for traditional fuel systems [7] - Shi Chang Co., Ltd. acknowledges the risk of declining demand for its products if the market for traditional fuel vehicles diminishes significantly due to advancements in electric vehicle technology [7]

Core Viewpoint - Chery Automobile has successfully completed its long-awaited IPO, with subscription dates from September 17 to 22 on the Hong Kong Stock Exchange, marking a significant milestone for the company after 21 years of efforts [3][10]. Group 1: Company Overview - Chery Automobile Co., Ltd. was founded in 1997 and is headquartered in Wuhu, China, producing both fuel and new energy vehicles, with a market presence in over 100 countries and regions [3]. - In 2024, Chery is projected to sell 2.6039 million vehicles, with exports exceeding 1.1445 million units, maintaining its position as the top Chinese brand in passenger car exports for 22 consecutive years [5]. Group 2: Financial Performance - Chery's revenue for 2022, 2023, and 2024 is expected to be RMB 92.618 billion, RMB 163.205 billion, and RMB 269.897 billion, respectively, with net profits of RMB 5.806 billion, RMB 10.444 billion, and RMB 14.334 billion for the same years [6][7]. - The first quarter of 2025 shows a revenue of RMB 68.223 billion, representing a year-on-year growth of 24.25%, and a net profit of RMB 4.726 billion, reflecting a significant increase of 90.87% [6]. Group 3: Market Position and Valuation - Chery is ranked first among the top twenty global passenger car companies, with a notable year-on-year growth of 49.4% in revenue for 2024 [5]. - The company has a low valuation, with a maximum expected price-to-earnings ratio of no more than 10 times, indicating a significant discount compared to industry peers [10].

Core Viewpoint - The company, JinHua New Materials, has initiated its IPO with a price of 18.15 yuan and a P/E ratio of 11.52 times, aiming to raise approximately 5.93 billion yuan for various projects [1][2]. Group 1: IPO Details - The initial issuance quantity is 32.67 million shares, with an online issuance of 26.13 million shares, and a total share capital post-issuance of 131 million shares [1][2]. - The company has authorized Zheshang Securities to allocate an additional 4.90 million shares to online investors, increasing the online issuance to 31.03 million shares [1][2]. - The strategic placement of shares amounts to 6.53 million shares, representing 20% of the initial issuance scale [1][2]. Group 2: Fundraising and Project Allocation - The total expected fundraising amount is 593 million yuan, which could increase to 682 million yuan if the overallotment option is fully exercised [1][2]. - The raised funds will be directed towards several projects, including: - 60kt/a high-end coupling agent project: 506.90 million yuan - Ketoxime silicon new materials research institute: 136.22 million yuan - Intelligent factory construction for the ketoxime industry chain: 63.11 million yuan - Marketing network construction: 38.61 million yuan - 500 tons/year JH-2 pilot project: 23 million yuan [2]. Group 3: Financial Performance - The company’s net profit for 2022, 2023, and 2024 is projected to be 79.59 million yuan, 173 million yuan, and 211 million yuan, respectively, with year-on-year changes of -67.34%, 116.74%, and 22.28% [2]. - Key financial indicators for 2024 include total assets of 1.32 billion yuan, net assets of 842.66 million yuan, and operating income of 1.24 billion yuan [3][4]. - The diluted earnings per share for 2024 is projected at 2.15 yuan, with a return on equity of 28.19% [4].

Group 1: Company Overview - The company operates as a national high-value medical device distributor, focusing on direct sales and distribution of medical devices, as well as providing centralized operation services for medical consumables to hospitals [2] - As of the signing date of the prospectus, Xiamen Jianfa Medical Health Investment Co., Ltd. holds 51.02% of the company's shares, making it the controlling shareholder [2] - The actual controller of the company is the Xiamen State-owned Assets Supervision and Administration Commission, which indirectly holds 51.02% of the company's shares through its ownership of Jianfa Group and Jianfa Medical [2] Group 2: Fundraising and Financials - The company plans to raise approximately 484.24 million yuan for projects including information system upgrades, centralized operation services for medical consumables, and to supplement working capital [2] - The initial public offering (IPO) price is set at 7.05 yuan per share, with an expected total fundraising amount of 445.51 million yuan, and a net fundraising amount of approximately 363.33 million yuan after deducting issuance costs [3] Group 3: Industry Context - The company plays a crucial role in the medical device supply chain, acting as a hub that connects manufacturers, distributors, and end medical institutions [2] - The reference industry price-earnings ratio for the wholesale industry is 25.73, while the company's offering price results in a price-earnings ratio of 13.29, indicating a potential undervaluation compared to industry peers [1]

Core Viewpoint - The article discusses the upcoming IPOs of two companies: Jianfa Zhixin and Jinhua New Materials, highlighting their business models, financial metrics, and market positions in their respective industries [1][10]. Group 1: Jianfa Zhixin (301584.SZ) - Jianfa Zhixin is a national high-value medical device distributor, primarily engaged in direct sales and distribution of medical devices, as well as providing centralized operation services for medical consumables [1][6]. - The company is controlled by Xiamen Jianfa Group, with a 51.02% stake held by Jianfa Medical, which is fully owned by Xiamen Jianfa Group [6]. - For 2024, Jianfa Zhixin's revenue is projected to be divided into three segments: direct sales (110.32 billion, 61.69%), distribution (67.38 billion, 37.68%), and service (1.12 billion, 0.63%) [6]. - The company serves over 3,300 medical institutions across 31 provinces, with major clients including Beijing Anzhen Hospital and Jilin University First Hospital [6]. - Jianfa Zhixin's fundraising will focus on upgrading information systems (1.4 billion), centralized operation services (1.04 billion), and working capital (2.4 billion) [5]. Group 2: Jinhua New Materials (920015.BJ) - Jinhua New Materials specializes in the research, production, and sales of ketoxime series fine chemicals, being a leading player in the domestic silane crosslinker segment [10][11]. - The company plans to invest in several projects, including a high-end coupling agent project (5.07 billion) and a ketone-based smart factory construction project (0.61 billion) [10]. - Jinhua New Materials holds a market share of 27.85%, 31.60%, and 38.16% in silane crosslinkers for the years 2022, 2023, and 2024, respectively [11]. - The company has received multiple honors, including being recognized as a "Little Giant" enterprise and a national high-tech enterprise [11]. - Jinhua New Materials faces potential risks from cyclical fluctuations in downstream industries, particularly in real estate and photovoltaic sectors, which may impact demand for its products [12].

Group 1 - The article discusses the stock issuance of United Power (stock code: 301656) with a subscription price of 12.48 yuan per share [1] - The industry price-earnings ratio is noted as 32.87, while the issuance price-earnings ratio is 29.08 [1] - The maximum subscription limit is set at 40,000 shares [1]

Group 1: New Stock Performance - The recent new stocks on the Beijing Stock Exchange have shown high activity, with the stock of Sanxie Electric rising over 860% on its first day, closing up 785.62%, marking the highest first-day increase of the year [1] - Aifenda's stock also saw a first-day increase of 170.03%, with a single subscription yield exceeding 16,000 yuan [1] Group 2: Upcoming New Stocks - Five new stocks are scheduled for subscription next week, including three from the ChiNext board, one from the Shenzhen main board, and one from the Beijing Stock Exchange [4] - The first stock to be subscribed on September 15 is United Power, a leader in the new energy vehicle power system industry, with a projected domestic market share of over 10% for its electric control and motor products by 2024 [1][6] Group 3: Financial Projections - United Power expects a net profit of 750 million to 900 million yuan for the first three quarters of 2025, representing a year-on-year growth of 31.05% to 57.26% [6][7] - Jianfa Zhixin anticipates a net profit of 200 million to 222 million yuan for the same period, reflecting a growth of 30% to 40% [8][10] - Ruili Kemi projects a net profit of 196 million to 220 million yuan, with a growth rate of 11.96% to 25.67% [11][12] - Yunhan Xincheng expects a net profit of 77 million to 80 million yuan, indicating a growth of 38.71% to 44.11% [13][14]

Group 1: Upcoming IPOs - Four new stocks are scheduled for subscription from September 15 to September 19, with key companies being Fangqu He Power, a leader in China's new energy vehicle power systems, and Ruili Kemi, a company developing active safety systems for automobiles [1] Group 2: Company Details - **United Power (Chuangye Board, 301656)**: - Subscription Date: September 15, Monday - Subscription Code: 3016 - Industry: Automotive Manufacturing - Issuance P/E Ratio: 32.87 - Industry Average P/E Ratio: 29.0 - Comparable Companies: Jingjin Electric, Ju Yi Technology, Yingboer - Highlight: Backed by controlling shareholder Huichuan Technology, the company has gradually developed into a leader in China's automotive power systems [2] - **Jianfa Zhixin (Chuangye Board, 301584)**: - Subscription Date: September 16, Tuesday - Subscription Code: 3015 - Industry: Wholesale - Issuance P/E Ratio: Not provided - Industry Average P/E Ratio: 25.7 [2] - **Ruili Kemi (Shenzhen Main Board, 001285)**: - Subscription Date: September 19, Friday - Subscription Code: 0012 - Industry: Computer, Communication, and Other Electronic Equipment Manufacturing - Issuance P/E Ratio: 53.1 - Industry Average P/E Ratio: Not provided - Comparable Companies: Wan'an Technology, Bertley, Rongtai Shares - Highlight: One of the few companies in China capable of developing active safety systems such as ABS and ESC, with core products widely used in commercial and passenger vehicles [3] - **Yunhan Xincheng (Chuangye Board, 301563)**: - Subscription Date: September 19, Friday - Subscription Code: 3015 - Industry: Wholesale - Issuance P/E Ratio: Not provided - Industry Average P/E Ratio: 25.7 - Comparable Companies: Liyuan Information, Runxin Technology, Shangluo Electronics - Highlight: The company is a leading player in the online distribution of electronic components in China [4]